Erythromelalgia is a characteristic thrombotic complication in patients with the myeloproliferative disorders, essential thrombocythemia and polycythemia vera. In this minireview, which is based on more than 20 years of clinical observations and intervention studies, the clinical manifestations, treatment, and pathogenesis of erythromelalgia are discussed.
No takes yet. Share an insight, caveat, or question.
Genderen et al. (1997) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: